Bora Pharmaceuticals Co., Ltd. (TPE:6472)
Taiwan · Delayed Price · Currency is TWD 482.00
+20.00 (4.33%)
Mar 5, 2026, 1:35 PM CST
Bora Pharmaceuticals Market Cap
Bora Pharmaceuticals has a market cap or net worth of 59.78 billion as of March 5, 2026. Its market cap has decreased by -33.51% in one year.
Market Cap
59.78B
Enterprise Value
76.92B
Revenue
21.10B
Ranking
n/a
PE Ratio
14.79
Stock Price
482.00
Market Cap Chart
Since October 3, 2014, Bora Pharmaceuticals's market cap has increased from 3.16B to 59.78B, an increase of 1,790.64%. That is a compound annual growth rate of 29.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 5, 2026 | 59.78B | -1.23% |
| Dec 31, 2025 | 60.52B | -22.12% |
| Dec 31, 2024 | 77.71B | 20.27% |
| Dec 29, 2023 | 64.61B | 107.61% |
| Dec 30, 2022 | 31.12B | 150.04% |
| Dec 30, 2021 | 12.45B | 17.05% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 23, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PharmaEssentia | 248.68B |
| Lotus Pharmaceutical | 67.06B |
| Center Laboratories | 36.84B |
| TTY Biopharm Company | 20.69B |
| Grape King Bio | 17.70B |
| ScinoPharm Taiwan | 15.85B |
| Synmosa Biopharma | 15.55B |
| YungShin Global Holding | 14.44B |